1 | Additional Representation Sheet | 25 Jan 2006 |
1 | TM-1 | 25 Jan 2006 |
10 | Correspondence | 04 Dec 2017 |
11 | Correspondence | 22 Dec 2017 |
12 | Correspondence | 08 Jan 2018 |
13 | Correspondence | 07 May 2018 |
14 | Correspondence | 25 May 2018 |
15 | Correspondence | 04 Jun 2018 |
16 | Correspondence | 08 Oct 2018 |
17 | Correspondence | 12 Nov 2018 |
18 | Correspondence | 18 Feb 2019 |
19 | Correspondence | 18 Mar 2019 |
2 | Power of Attorney | 25 Jan 2006 |
20 | Correspondence | 14 Aug 2019 |
3 | Additional Representation Sheet | 25 Jan 2006 |
3 | TM-1 | 25 Jan 2006 |
4 | TM-16 | 12 Jun 2009 |
5 | Correspondence | 17 Nov 2014 |
6 | Reply to Exam Report (MIS-R) | 12 Apr 2017 |
7 | Reply to Exam Report (MIS-R) | 12 Apr 2017 |
8 | Correspondence | 20 Jul 2017 |
9 | Correspondence | 28 Aug 2017 |
The application for Ensamycin was made on 27 January 2006.
The trademark applicant for Ensamycin is FULFORD INDIA.
Ensamycin is applied in class(es) 5.
Application for Ensamycin is on Opposed stage.
Application Id allotted to Ensamycin is 1416985.
Trademark agent or attorney for the application is Crawford Bayley & Co.
Ensamycin filed with the Intellectual property office as a WORD.